Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 44%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is experiencing strong growth potential and has a diverse leadership team with a focus on sustainability and compliance. Their recent acquisition of Family First and planned wage increases for caregivers, along with a growing mix of home health services, make them well-positioned for success. However, the company faces risks such as potential government reimbursement changes and nurse availability, and future performance will depend on their ability to maintain strong partnerships and continue growing their preferred payor relationships.

Bears say

Aveanna Healthcare Hldgs is showing strong financial performance, with multiple new preferred payor agreements signed and a steady increase in episodic mix, leading to expectations of double-digit growth in revenue and stabilization of margins in the mid-40% range. There are also opportunities for the company to realize cost savings and efficiency gains through AI and technology implementation. However, there are also risks related to changes in government reimbursement policies and a tight labor market for nursing staff that could negatively affect the company's operations.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 44% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of Sep 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.